2025年2月13日 · Veru is a biopharmaceutical company focused on developing novel medicines for high-quality weight loss, breast cancer, and viral related ARDS

Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic and inflammatory diseases. The Company’s drug …

Veru is a biopharmaceutical company focused on developing novel medicines for cardiometabolic and inflammatory diseases. Our drug development program consists of two late-stage new …

Veru is a biopharmaceutical company focused on developing novel medicines for high-quality weight loss, breast cancer, and viral related ARDS.

1990年7月1日 · Veru Inc是一家生物制药公司，拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征（ARDS）的药物开发项目。 该公司还处于某些治疗乳腺癌和前列腺癌药物的后期开发阶段。

4 天之前 · Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). …

2025年3月21日 · Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. …

2024年12月31日 · Veru Inc. has sold its FC2 Female Condom business for $18 million to Riva Ridge Capital Management and other co-investors, allowing the company to concentrate on its …

2025年1月27日 · --Veru Inc., a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, …

2024年12月17日 · Veru (VERU) delivered earnings and revenue surprises of 14.29% and 86.99%, respectively, for the quarter ended September 2024. Do the numbers hold clues to …